Aditya Birla Sun Life Pharma & Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 20-12-2024
NAV ₹31.19(R) -0.83% ₹33.99(D) -0.85%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 37.58% 19.56% 24.23% -% -%
LumpSum (D) 39.47% 21.29% 26.17% -% -%
SIP (R) -27.02% 25.24% 21.75% -% -%
SIP (D) -25.89% 27.05% 23.54% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.66 0.36 0.66 0.12% 0.11
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.13% -16.59% -17.36% 0.96 10.91%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Dsp Healthcare Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 20-12-2024

Scheme Name NAV Rupee Change Percent Change
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular - Payout of IDCW 21.9
-0.1900
-0.8600%
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct - Payout of IDCW 23.5
-0.2000
-0.8400%
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 31.19
-0.2600
-0.8300%
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth 33.99
-0.2900
-0.8500%

Review Date: 20-12-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It indicates the appreciation in the investment's value within the investment period, represented as a percentage or a specific amount of money. We conducted an analysis of the six return parameters of this fund to assess their performance. To assess performance, we have segmented the return parameters into three groups: the top 25%, parameters below the top 25% but still above average, and parameters below average. The results are provided below.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: One return parameter of the Aditya Birla Sun Life Pharma & Healthcare Fund is above average but below the top 25% in the category, as listed below:
      • 1M Return %
    3. Below Average: Aditya Birla Sun Life Pharma & Healthcare Fund has five return parameters that are below average in the category, which are listed below:
      • 1Y Return %
      • 5Y Return %
      • 3Y Return %
      • 6M Return %
      • 3M Return %
  2. Risk: Various factors can lead to the risk of either not meeting expected returns or encountering a monetary loss. For Aditya Birla Sun Life Pharma & Healthcare Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Aditya Birla Sun Life Pharma & Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Aditya Birla Sun Life Pharma & Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Aditya Birla Sun Life Pharma & Healthcare Fund has two parameters that are above average which are listed below:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 16.13 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.91 %.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Aditya Birla Sun Life Pharma & Healthcare Fund, we have evaluated four risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: Aditya Birla Sun Life Pharma & Healthcare Fund has four risk-adjusted performance parameters of the fund that are below average in the category.
      • Sharpe Ratio: Aditya Birla Sun Life Pharma & Healthcare Fund has a Sharpe Ratio of 0.66 compared to the category average of 0.88.
      • Sterling Ratio: Aditya Birla Sun Life Pharma & Healthcare Fund has a Sterling Ratio of 0.66 compared to the category average of 0.8.
      • Sortino Ratio: Aditya Birla Sun Life Pharma & Healthcare Fund has a Sortino Ratio of 0.36 compared to the category average of 0.48.
      • Treynor Ratio: Aditya Birla Sun Life Pharma & Healthcare Fund has a Treynor Ratio of 0.11 compared to the category average of 0.15.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.01
2.88
-0.97 | 4.52 7 | 13 Good
3M Return % -2.26
-0.40
-9.73 | 3.09 12 | 13 Average
6M Return % 14.71
19.11
3.40 | 26.27 12 | 13 Average
1Y Return % 37.58
42.49
33.84 | 51.93 10 | 12 Poor
3Y Return % 19.56
22.41
19.56 | 25.88 8 | 8 Poor
5Y Return % 24.23
28.25
24.23 | 30.74 8 | 8 Poor
1Y SIP Return % -27.02
-21.85
-35.24 | -12.91 11 | 12 Poor
3Y SIP Return % 25.24
28.17
25.24 | 32.64 8 | 8 Poor
5Y SIP Return % 21.75
24.81
21.75 | 27.67 8 | 8 Poor
Standard Deviation 16.13
15.42
14.47 | 16.13 8 | 8 Poor
Semi Deviation 10.91
10.54
10.13 | 10.91 8 | 8 Poor
Max Drawdown % -17.36
-16.50
-18.92 | -14.27 6 | 8 Average
VaR 1 Y % -16.59
-16.74
-18.91 | -14.68 3 | 8 Good
Average Drawdown % -6.76
-5.35
-6.76 | -4.22 8 | 8 Poor
Sharpe Ratio 0.66
0.88
0.66 | 1.12 8 | 8 Poor
Sterling Ratio 0.66
0.80
0.66 | 1.02 8 | 8 Poor
Sortino Ratio 0.36
0.48
0.36 | 0.65 8 | 8 Poor
Jensen Alpha % 0.12
4.05
0.12 | 8.16 8 | 8 Poor
Treynor Ratio 0.11
0.15
0.11 | 0.19 8 | 8 Poor
Modigliani Square Measure % 18.32
22.51
18.32 | 27.03 8 | 8 Poor
Alpha % -0.61
2.41
-0.61 | 6.00 8 | 8 Poor
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.13 2.99 -0.84 | 4.64 7 | 13
3M Return % -1.90 -0.08 -9.36 | 3.54 12 | 13
6M Return % 15.53 19.88 4.26 | 27.36 12 | 13
1Y Return % 39.47 44.30 36.04 | 53.85 10 | 12
3Y Return % 21.29 23.89 21.29 | 27.00 8 | 8
5Y Return % 26.17 29.86 26.17 | 32.66 8 | 8
1Y SIP Return % -25.89 -20.75 -34.00 | -11.70 11 | 12
3Y SIP Return % 27.05 29.75 27.01 | 33.82 7 | 8
5Y SIP Return % 23.54 26.34 23.54 | 28.81 8 | 8
Standard Deviation 16.13 15.42 14.47 | 16.13 8 | 8
Semi Deviation 10.91 10.54 10.13 | 10.91 8 | 8
Max Drawdown % -17.36 -16.50 -18.92 | -14.27 6 | 8
VaR 1 Y % -16.59 -16.74 -18.91 | -14.68 3 | 8
Average Drawdown % -6.76 -5.35 -6.76 | -4.22 8 | 8
Sharpe Ratio 0.66 0.88 0.66 | 1.12 8 | 8
Sterling Ratio 0.66 0.80 0.66 | 1.02 8 | 8
Sortino Ratio 0.36 0.48 0.36 | 0.65 8 | 8
Jensen Alpha % 0.12 4.05 0.12 | 8.16 8 | 8
Treynor Ratio 0.11 0.15 0.11 | 0.19 8 | 8
Modigliani Square Measure % 18.32 22.51 18.32 | 27.03 8 | 8
Alpha % -0.61 2.41 -0.61 | 6.00 8 | 8
Return data last Updated On : Dec. 20, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D -0.83 ₹ 9,917.00 -0.85 ₹ 9,915.00
1W 1.17 ₹ 10,117.00 1.19 ₹ 10,119.00
1M 3.01 ₹ 10,301.00 3.12 ₹ 10,312.00
3M -2.26 ₹ 9,774.00 -1.90 ₹ 9,810.00
6M 14.71 ₹ 11,471.00 15.53 ₹ 11,553.00
1Y 37.58 ₹ 13,758.00 39.47 ₹ 13,947.00
3Y 19.56 ₹ 17,090.00 21.29 ₹ 17,843.00
5Y 24.23 ₹ 29,592.00 26.17 ₹ 31,976.00
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 -27.02 ₹ 10,160.92 -25.89 ₹ 10,241.69
3Y ₹ 36000 25.24 ₹ 51,925.25 27.05 ₹ 53,221.25
5Y ₹ 60000 21.75 ₹ 103,036.26 23.54 ₹ 107,581.14
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Aditya Birla Sun Life Pharma & Healthcare Fund NAV Regular Growth Aditya Birla Sun Life Pharma & Healthcare Fund NAV Direct Growth
20-12-2024 31.19 33.99
19-12-2024 31.45 34.28
18-12-2024 31.1 33.89
17-12-2024 30.68 33.43
16-12-2024 30.9 33.66
13-12-2024 30.83 33.59
12-12-2024 30.88 33.65
11-12-2024 31.08 33.86
10-12-2024 31.06 33.83
09-12-2024 31.05 33.82
06-12-2024 31.06 33.83
05-12-2024 31.1 33.87
04-12-2024 31.1 33.87
03-12-2024 31.15 33.93
02-12-2024 31.03 33.79
29-11-2024 30.85 33.59
28-11-2024 30.28 32.98
27-11-2024 30.42 33.12
26-11-2024 30.57 33.29
25-11-2024 30.91 33.65
22-11-2024 30.64 33.35
21-11-2024 30.28 32.96

Fund Launch Date: 11/Jul/2019
Fund Category: Pharma Fund
Investment Objective: The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/ indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare Services Sector
Fund Benchmark: S&P BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.